Alzamend Neuro, Inc. (ALZN) - Latest Market Data

Price & Market Data

Price: $1.13

Daily Change: -$0.04 / 3.54%

Daily Range: $1.11 - $1.21

Market Cap: $4,299,357

Daily Volume: 62,201

Performance Metrics

1 Week: 14.85%

1 Month: 5.45%

3 Months: -42.00%

6 Months: -42.00%

1 Year: -67.60%

YTD: -36.96%

About Alzamend Neuro, Inc. (ALZN)

Summarized market data for Alzamend Neuro, Inc. (ALZN). Price: 1.13, daily change: -$0.04 / 3.54%. Market cap: 4,299,357. Performance over 3-month and 6-month periods.

Company Details

Employees: 7

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Selected stocks

Motorsport Games Inc. (MSGM)

Wellgistics Health, Inc. (WGRX)

Giftify, Inc. (GIFT)

PMGC Holdings Inc. (ELAB)